Belize vs Jamaica: Access to anti-retroviral drugs, male
Belize
48.0%
in 2024
Jamaica
47.0%
in 2024
Belize rank
120th
Jamaica rank
122nd
Access to anti-retroviral drugs, male over time
- Belize
- Jamaica
How they compare
Belize currently reports 48.0% against 47.0% in Jamaica, a difference of 1.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Jamaica ahead.
Belize ranks 120th and Jamaica ranks 122nd of 141 countries.
Across the 3 decades both report, Belize averaged higher in 2 and Jamaica in 1.
Head to head by decade
| Decade | Belize | Jamaica | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.9% | 4.2% | 4.7% | Belize |
| 2010s | 30.8% | 29.1% | 1.7% | Belize |
| 2020s | 42.2% | 43.8% | 1.6% | Jamaica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Belize or Jamaica?
- Belize, at 48.0% against 47.0% in Jamaica as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Belize and Jamaica?
- 1.0%, with Belize ahead.
- How many years of comparable data are there for Belize and Jamaica?
- 25 years are reported by both, from 2000 to 2024.
- How do Belize and Jamaica rank globally for access to anti-retroviral drugs, male?
- Belize ranks 120th and Jamaica ranks 122nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.